Cao, M., Li, H., Sun, D. & Chen, W. Cancer burden of major cancers in China: A need for sustainable actions. Cancer Commun. Lond. Engl. 40, 205–210 (2020).
Google Scholar
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209–249 (2021).
Google Scholar
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C. & Lordick, F. Gastric cancer. Lancet 396, 635–648 (2020).
Google Scholar
Tan, Z. Recent advances in the surgical treatment of advanced gastric cancer: A review. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 25, 3537–3541 (2019).
Caruso, S. & Scatizzi, M. Laparoscopic gastrectomy for gastric cancer: Has the time come for considered it a standard procedure?. Surg. Oncol. 40, 101699 (2022).
Google Scholar
Lu, S. et al. A phase III trial of neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis. Future Oncol. 18, 1175–1183 (2022).
Google Scholar
Ng, S. P. & Leong, T. Role of radiation therapy in gastric cancer. Ann. Surg. Oncol. 28, 4151–4157 (2021).
Google Scholar
Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y. & Shitara, K. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: An emerging paradigm. Nat. Rev. Clin. Oncol. 18, 473–487 (2021).
Google Scholar
Kole, C. et al. Immunotherapy for gastric cancer: A 2021 update. Immunotherapy 14, 41–64 (2022).
Google Scholar
Takei, S., Kawazoe, A. & Shitara, K. The new era of immunotherapy in gastric cancer. Cancers 14, 1054 (2022).
Google Scholar
Joshi, S. S. & Badgwell, B. D. Current treatment and recent progress in gastric cancer. CA. Cancer J. Clin. 71, 264–279 (2021).
Google Scholar
Wilke, H. et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): A double-blind, randomised phase 3 trial. Lancet Oncol. 15, 1224–1235 (2014).
Google Scholar
Kang, Y.-K. et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 390, 2461–2471 (2017).
Google Scholar
Fuchs, C. S. et al. Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial. Gastric Cancer 25, 197–206 (2022).
Google Scholar
Smith, R. J. & Bryant, R. G. Metal substitutions incarbonic anhydrase: A halide ion probe study. Biochem. Biophys. Res. Commun. 66, 1281–1286 (1975).
Google Scholar
Chen, L.-T. et al. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data. Gastric Cancer 23, 510–519 (2020).
Google Scholar
Chaganty, B. K. R. et al. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion. Cancer Lett. 430, 47–56 (2018).
Google Scholar
Kono, K., Nakajima, S. & Mimura, K. Current status of immune checkpoint inhibitors for gastric cancer. Gastric Cancer 23, 565–578 (2020).
Google Scholar
Nishino, M., Ramaiya, N. H., Hatabu, H. & Hodi, F. S. Monitoring immune-checkpoint blockade: Response evaluation and biomarker development. Nat. Rev. Clin. Oncol. 14, 655–668 (2017).
Google Scholar
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).
Google Scholar
Liu, Y. et al. AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma. Sci. Rep. 12, 4272 (2022).
Google Scholar
Wei, X. et al. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. Aging 12, 24184–24207 (2020).
Google Scholar
Wu, D. et al. Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis. Sci. Rep. 11, 8069 (2021).
Google Scholar
Yu, L. et al. Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis. Sci. Rep. 11, 11926 (2021).
Google Scholar
Yu, M. et al. A risk model of eight immune-related genes predicting prognostic response to immune therapies for gastric cancer. Genes 13, 720 (2022).
Google Scholar
Xu, X. et al. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients. Cancer Cell Int. 21, 117 (2021).
Google Scholar
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Google Scholar
Zhang, X. et al. Cell Marker: A manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47, D721–D728 (2019).
Google Scholar
Sun, D. et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat. Biotechnol. 40, 527–538 (2022).
Google Scholar
Jin, S. et al. Inference and analysis of cell-cell communication using cell chat. Nat. Commun. 12, 1088 (2021).
Google Scholar
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587–D592 (2023).
Google Scholar
De Falco, A., Caruso, F., Su, X.-D., Iavarone, A. & Ceccarelli, M. A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data. Nat. Commun. 14, 1074 (2023).
Google Scholar
Compare, D., Rocco, A. & Nardone, G. Risk factors in gastric cancer. Eur. Rev. Med. Pharmacol. Sci. 14, 302–308 (2010).
Google Scholar
Wei, M. et al. The progress of T cell immunity related to prognosis in gastric cancer. BioMed Res. Int. 2018, 3201940 (2018).
Google Scholar
Lin, C. et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut 68, 1764–1773 (2019).
Google Scholar
Zeng, D. et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol. Res. 7, 737–750 (2019).
Google Scholar
Liu, Y. et al. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J. Transl. Med. 18, 201 (2020).
Google Scholar
Qing, X. et al. Molecular characteristics, clinical significance, and cancer immune interactions of angiogenesis-associated genes in gastric cancer. Front. Immunol. 13, 843077 (2022).
Google Scholar
Guo, F. et al. Correlation between TNFAIP2 gene polymorphism and prediction/prognosis for gastric cancer and its effect on TNFAIP2 protein expression. Front. Oncol. 10, 1127 (2020).
Google Scholar
Xu, Y. et al. The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer. PLoS ONE 8, e64973 (2013).
Google Scholar
Zhu, T., Lou, Q., Shi, Z. & Chen, G. Identification of key miRNA-gene pairs in gastric cancer through integrated analysis of mRNA and miRNA microarray. Am. J. Transl. Res. 13, 253–269 (2021).
Google Scholar
Zhong, Z. et al. Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data. Ann. Transl. Med. 8, 115 (2020).
Google Scholar
Wang, C. et al. Distinct prognostic roles of S100 mRNA expression in gastric cancer. Pathol. Res. Pract. 215, 127–136 (2019).
Google Scholar
Zhang, J. et al. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer. Ann. Transl. Med. 10, 698 (2022).
Google Scholar
Huang, P., Liu, Y. & Jia, B. The expression, prognostic value, and immunological correlation of MCEMP1 and its potential role in gastric cancer. J. Oncol. 2022, 8167496 (2022).
Google Scholar
Wang, D. et al. MCEMP1 is a potential therapeutic biomarker associated with immune infiltration in advanced gastric cancer microenvironment. Gene 840, 146760 (2022).
Google Scholar
Hu, G., Sun, N., Jiang, J. & Chen, X. Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis. Cancer Cell Int. 20, 433 (2020).
Google Scholar
Yao, X. et al. SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int. 20, 503 (2020).
Google Scholar
Lin, L. et al. Prognostic value of the ferroptosis-related gene SLC2A3 in gastric cancer and related immune mechanisms. Front. Genet. 13, 919313 (2022).
Google Scholar
Chen, D. et al. MicroRNA-129-5p regulates glycolysis and cell proliferation by targeting the glucose transporter SLC2A3 in gastric cancer cells. Front. Pharmacol. 9, 502 (2018).
Google Scholar
Li, L., Meng, Q., Li, G. & Zhao, L. BASP1 suppresses cell growth and metastasis through inhibiting wnt/β-catenin pathway in gastric cancer. BioMed Res. Int. 2020, 8628695 (2020).
Google Scholar
Xin, D., Man, Y., Yang, Y. & Wang, F. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer. Front. Genet. 13, 953997 (2022).
Google Scholar
Zheng, X. et al. Construction and analysis of the tumor-specific mRNA–miRNA–lncRNA network in gastric cancer. Front. Pharmacol. 11, 1112 (2020).
Google Scholar
Gong, Y. et al. Development of a prognostic metabolic signature in stomach adenocarcinoma. Clin. Transl. Oncol. 24, 1615–1630 (2022).
Google Scholar
Katoh, M. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation (review). Int. J. Mol. Med. 42, 713–725 (2018).
Google Scholar
Tang, W. et al. Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect. Agent. Cancer 7, 21 (2012).
Google Scholar
Khan, M. et al. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma. Front. Immunol. 13, 968165 (2022).
Google Scholar
Chen, Y. et al. The immune subtypes and landscape of gastric cancer and to predict based on the whole-slide images using deep learning. Front. Immunol. 12, 685992 (2021).
Google Scholar
Wei, J., Zeng, Y., Gao, X. & Liu, T. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer. BMC Cancer 21, 1221 (2021).
Google Scholar
Huo, J., Wu, L. & Zang, Y. Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability. Epigenomics 13, 875–890 (2021).
Google Scholar
Cheong, J.-H. et al. Development and validation of a prognostic and predictive 32-gene signature for gastric cancer. Nat. Commun. 13, 774 (2022).
Google Scholar
Chen, W. et al. Identification of ferroptosis-related long noncoding RNA and construction of a novel prognostic signature for gastric cancer. Dis. Markers 2021, 7724997 (2021).
Google Scholar
Cai, W.-Y. et al. Identification of a tumor microenvironment-relevant gene set-based prognostic signature and related therapy targets in gastric cancer. Theranostics 10, 8633–8647 (2020).
Google Scholar
Dai, W. et al. Identification of an EMT-related gene signature for predicting overall survival in gastric cancer. Front. Genet. 12, 661306 (2021).
Google Scholar
Cai, H. et al. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J. Transl. Med. 17, 189 (2019).
Google Scholar
Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437 (2013).
Google Scholar
Pitt, J. M. et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann. Oncol. 27, 1482–1492 (2016).
Google Scholar
Wang, X. C., Zhang, J. Q., Shen, Y. Q., Miao, F. Q. & Xie, W. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. J. Exp. Clin. Cancer Res. 25, 115–119 (2006).
Google Scholar
Takahashi, A. et al. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. Clin. Cancer Res. 7, 74–80 (2001).
Google Scholar
Dunn, G. P., Old, L. J. & Schreiber, R. D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329–360 (2004).
Google Scholar
Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).
Google Scholar
Gao, Q. et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25, 2586–2593 (2007).
Google Scholar
